U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Nolte E, Knai C, editors. Assessing Chronic Disease Management in European Health Systems: Country reports [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2015. (Observatory Studies Series, No. 39.)

Cover of Assessing Chronic Disease Management in European Health Systems

Assessing Chronic Disease Management in European Health Systems: Country reports [Internet].

Show details

13Switzerland

, , , and .

13.1. The health care system

Switzerland is a democratic federal state characterized by a high level of political decentralization. The 26 states (cantons) have their own constitution, parliament, government and courts. The Swiss health system is financed mainly from mandatory social insurance (2012: 43.7%), complemented by OOP payments (28.1%), taxation (18.0%) and voluntary insurance (9.4%) (WHO, 2014). In 2012, national health care expenditure in Switzerland was 11.3% of GDP.

Decision-making in the health system is shared between the federal and regional level, with the federal government legislating in areas such as public health, social insurance and professional qualifications, while the cantons are responsible for disease prevention and health education and for the provision of health care; they also partially finance hospital costs. As a result of the high level of decentralization, the Swiss health care system is sometimes considered as being comprised of 26 (slightly) different systems.

The 1996 Federal Health Insurance Act (Loi fédérale sur l’assurance-maladie; LAMal) stipulates that all Swiss residents purchase basic health insurance which covers a comprehensive basket of goods and services defined at the federal level (Paris & Docteur, 2007). All insurers are private; those offering the basic basket must be non-profit-making and they must accept all applicants for membership during specified open-enrolment periods (Leu et al., 2009). Insurance premiums are community-rated and although a risk-equalization scheme is in place, risk selection remains a problem; in 2012, 29% of the population received state subsidies (from taxation) because of low income (Federal Office of Public Health, 2013a).

There are several cost-sharing arrangements, with all individuals contributing to the cost of health services through a deductible, co-insurance and co-payments (minimum annual deductible of CHF 300 and co-insurance of 10% up to a maximum of CHF 700 for all care) (Camenzind, 2013). Swiss cost-sharing is considered high by international standards (Leu et al., 2009). Many residents have complementary insurance to cover services excluded from the basic basket.

Ambulatory care is provided by primary care physicians and specialists working mainly independently in solo private practice and in small group practices. About half of the primary care physicians are embedded in one of 86 managed care organizations (networks of physicians and health maintenance organizations). This is mostly the case in the German-speaking part of Switzerland, but less so in the French- and Italian-speaking parts of the country. Hospitals also provide regular ambulatory as well as emergency care. Patients generally have direct and unrestricted access to primary care physicians and specialists. In 2014, about 24% of residents were enrolled in some form of managed care plan (Forum Managed Care, 2014a), of which two-thirds feature GP gatekeeping although specialists can also act as gatekeepers (Squires, 2009). Independent private practitioners (physicians) as well as other independent health care professionals (for example, nurses, physiotherapists, dentists) are generally paid on a fee-for-service basis; some managed-care plans operate capitation models.

Hospital care is provided by public and private hospitals, with the latter qualifying for financial subsidies from the state if they are considered of ‘public interest’. Public hospitals include the five Swiss university hospitals as well as cantonal and regional hospitals; they constitute the main form of inpatient care. Until 2011, hospitals were mainly reimbursed on a per-diem basis. Since 2012, prospective payment using DRGs (SwissDRG), adapted from the DRG system in place in Germany, is being implemented (Camenzind, 2013). Hospital-based physicians are paid either a salary or a mix of salary and fee-for-service, depending on seniority (Squires, 2009).

Health care reforms of relevance to chronic disease

The 1996 Federal Health Insurance Act and its subsequent revisions, in particular in relation to managed care and hospital financing, form the key health reforms of importance for chronic disease management in the Swiss health care system. As mentioned above, it introduced universal access to comprehensive health care services for all Swiss residents. Its third revision, in progress since 2004, further considered, among other things, legislative modifications of managed care (see below) and hospital financing. The latter resulted in the full conversion of hospital payment to the SwissDRG system in 2012 as noted earlier. However, the proposed revision promoting managed care was rejected by popular referendum in June 2012.

Since 2007, the Federal Council has also been developing a federal law on health promotion and disease prevention, aimed at improving the conduct, coordination and evaluation, at a national level, of health promotion and disease prevention. It was expected to define the roles of the confederation, cantons and nongovernmental organizations, as well as specifying national targets for health promotion and disease prevention and the allocation of funding according to this strategy. The development of the federal law on health promotion and disease prevention was however adjourned in September 2012.

More recently, in January 2013, the Federal Council presented ‘Health2020’, a comprehensive health care strategy, which seeks to prepare the Swiss health system for ‘the challenges ahead at affordable costs’ (Federal Office of Public Health, 2013b). It identifies four priority areas: quality of health care provision, quality of life, equality of opportunity and transparency, and its strategy focuses on chronic disease prevention and care, financing and insurance transformations, data transparency and e-health, as well as education and training of health care professionals.

Reform efforts that are currently being discussed and that are likely to contribute to the prevention and care of chronic diseases include the proposed consideration of primary care medicine in the Swiss constitution, following a national vote in May 2014, and the master plan family medicine, aimed at reinforcing primary care.

Current legal, regulatory and policy frameworks

Switzerland has so far not developed a national regulatory framework targeting chronic diseases prevention and management care although national programmes and strategies targeting specific areas such as tobacco, alcohol, physical activity and diet have been in place for some time. Strategies addressing chronic diseases more generally are more recent. However, all these strategies are not binding, and cantons remain free to organize health care delivery.

Currently, managed care as set out in the Federal Health Insurance Act represents the principal regulatory and policy framework for chronic disease management in Switzerland. However, it is not obligatory to implement chronic care initiatives within that framework. Within managed care, patients enrol with a physician who acts as a gatekeeper to specialist care in return for reduced premiums. The most common forms of managed care are physician networks and health maintenance organizations (HMOs). Within HMOs, physicians work in a group practice owned by a health insurer or by physicians while physician networks bring together office-based doctors in ambulatory care, usually in the form of family physician or gatekeeper models although increasingly also involving specialists (Strehle & Weber, 2008). Throughout the following text, we will refer to physician networks only.

The development of managed care schemes in Switzerland dates from the early 1990s; by 2014, there were 75 physicians networks, four-fifths of which had agreements to share part of the financial risk (Forum Managed Care, 2014b). About 24% of residents across Switzerland are currently enrolled with physician networks although coverage varies widely, with up to one-third of the population enrolled in some cantons while other regions have yet to implement networks. About half of all primary care physicians participate in networks.

As indicated above, from 2004, the Federal Council considered a further advancement of managed care models within the third revision of the Federal Health Insurance Act, with the main objective to promote the quality of care at reasonable and appropriate cost. The proposed legislation foresaw the strengthening of managed care, broadly referred to as integrated care (networks), through, among other things, requiring health insurers to contract with at least one integrated care network to be offered to their insured population (Cassis, 2010). However, as noted, following several years of development, the ‘managed care’ proposal was considered in a popular referendum and 76% of the population and all 26 cantons rejected the proposed plans.

Individual cantons have also engaged in advancing the regulatory and policy framework for chronic disease management, with, for example, the canton of Vaud, in its 2008–2012 health policy (Rapport du Conseil d’État sur la politique sanitaire 2008–2012) aiming to adapt health care services to chronic diseases, in particular reinforcing cooperation and coordination, and to promote health, prevent diseases and conduct priority public health programmes. In that context, the Ministry of Health of the canton of Vaud developed a cantonal diabetes programme, aimed at controlling the incidence of diabetes and at improving care for diabetic patients (see below).

13.2. Approaches to chronic disease management

Given the diversity of the Swiss health care system, and in the absence of a unified strategic approach to the management of chronic diseases, we here describe selected local and regional initiatives. We focus on approaches implemented in the French-speaking part of Switzerland. While recognizing that these are not representative of the entire country, we consider them typical of ‘cantonal’ approaches to chronic disease management in Switzerland. Unpublished data from a survey conducted by the lead author showed that initiatives are being developed throughout Switzerland.

Diabetes disease management programme Diabaide, canton of Vaud

Diabaide (Filière de soins Diabaide; ‘diabetes care network’) was developed in 2004 in western Switzerland. The programme was mainly led by a physician (endocrinologist–diabetologist) and a diabetes nurse-specialist. It was based on an inventory of the needs of diabetic patients in the region and the creation of a working group including a range of health care stakeholders involved in diabetes care. Initially, the programme included the provision of information material and continuing education for health care professionals only. It was expanded to form a more comprehensive programme directly targeting the patient.

The programme was jointly run by the Association Réseau de Soins de la Côte (one of five care networks operating in the canton of Vaud3) and two regional hospitals (Ensemble Hospitalier de la Côte and Groupement Hospitalier de l’Ouest Lémanique). While the hospitals provided the setting for service provision within Diabaide, services were not targeted at inpatients but are community-based.

The key components of Diabaide were disease management and multidisciplinary teams (cellule multidisciplinaire diabaide). The programme is currently being reorganized (see below); in the following we describe the core components implemented originally. This included the programme’s main strategies which involved elements of self-management support, delivery system design, decision support and clinical information systems.

  • Self-management support involved the provision of information material (French language), customized face-to-face self-management education and follow-up, and support by trained staff (nurse specialists, dieticians and specialist physicians). The patient’s overall situation was regularly assessed and patients were actively involved in goal setting and developing a treatment plan.
  • Delivery system design included the clear definition of the roles and tasks of each participating health professional, monthly meetings of the entire team and weekly coordination or organizational meetings, and the development of care plans for typical ‘clinical situations’ such as the introduction of insulin, gestational diabetes, which were then adapted to the specific context of the individual patient. Patients were followed up (in person or by telephone) following a predetermined schedule, including telephone contact at least once a year.
  • Decision support involved the use of care protocols developed according to international and Swiss guidelines, and the involvement of specialist physicians in the programme.
  • Clinical information systems included the implementation of a shared electronic medical record permitting restricted information sharing among health professionals involved in the care process (‘customized‘ access). This system also included an electronic booking system.

The programme offered specialized ambulatory care, along with access to a network of specialists such as endocrinologists, dieticians, diabetes nurses and podologists (Peytremann-Bridevaux & Burnand, 2009). GPs and family physicians did not assume an active role in the programme.

Any patient with type 1 or type 2 diabetes residing in the region of Nyon-Morges in the canton of Vaud was able to join the programme. However, participation in the programme was strongly dependent on whether or not the primary care physician referred patients to the programme. In addition, patients seen once were not to be followed further.

Initially supported by health insurers and the canton of Vaud, the programme is currently funded by the canton of Vaud (around 50%) and from care activities charged to the patient and reimbursed by their health insurers (around 50%). The objective of Diabaide was to cover 30% of the estimated diabetic population in the region of Nyon-Morges (around 6000). By 2009, a total of 720 patients (12%) had been reached. This equated to 100– 150 new patients, who were seen at least once a year.

Despite these encouraging results, there has been a lack in the steering, management and organization of Diabaide and as a consequence, Diabaide has been in the process of reorganization since 2013. This reorganization is moving towards fragmentation of its activities with specialized ‘poles’ developed by local institutions in collaboration with independent health care professionals. An external evaluation is under way which aims at a better understanding of the situation and previous experiences, and to explore how experiences can be used for further cantonal developments.

Evaluation

In 2006, Diabaide was formally evaluated by the Institute of Social and Preventive Medicine of Lausanne (Arditi & Burnand, 2008). The external evaluation aimed to assess (1) the activities of Diabaide and to describe the characteristics of the patients participating in the programme; (2) the effectiveness of the programme on clinical outcomes; and (3) the cost–effectiveness of the programme as compared with usual care. Using a pre–post design assessing the period between the start of the programme (2004) and 2006 and a mix of routine and newly collected data, the evaluation considered process indicators, including the number of patients enrolled and the number of consultations as well as intermediate outcome measures such as glycemic (Hb1AC and fasting glucose) and lipid levels, blood pressure and BMI. The evaluation found that the programme had been successfully implemented. However, the small number of patients included reflects the low participation of GPs and family physicians. It also indicated that among patients included in the analysis, outcomes had improved in terms of a reduction in mean HbA1c, total cholesterol level and blood pressure.

Breast cancer clinical pathway, Lausanne University Hospital and University of Lausanne

The breast cancer clinical pathway in Lausanne was implemented in 2008/2009 at the initiative of clinicians and clinical managers at Lausanne University Hospital to improve the quality and efficiency of health care. It was accredited by the Swiss Cancer League and the Swiss Senology Society label for breast cancer in November 2013. The breast cancer pathway, initiated by the Medical Directors’ Board, heads of hospital departments and hospital clinicians, was designed to improve the quality of care, and developed de novo. It is hospital-based and targets adults with breast cancer who are primarily treated at Lausanne University Hospital. As such, it does not involve primary care physicians.

The key components of the breast cancer clinical pathway are coordinated and integrated care as well as multidisciplinary teams. The pathway’s main strategies involve elements of self-management support, delivery system design, decision support and clinical information systems.

  • Self-management support involves information for patients using written documentation on a range of topics including the disease process as well as treatments and therapies; dedicated time during the individual consultation including information and regular reassessment of the patient’s situation; shared decision-making within a limited frame; and self-management support by trained nurses and social workers; and possible access to peer support groups. Self-management education following resection of axillary lymph nodes is also available.
  • Delivery system design includes a detailed description of each step of the clinical pathway; regular meetings with staff and project leads; and planned, predetermined and structured face-to-face consultations. This component also considers regular assessments of pathway implementation (routine process indicator measures).
  • Decision support involves the adaptation of (inter) national guidelines developed by the National Cancer Care Network and the Consensus of Saint-Gall (European guidelines) as well as provider education on specific components of the programme. Physicians and nurses involved in the programme also receive education in the field of senology–oncology and in communication. Hospital specialists are entirely integrated in the programme. Clinicians are further supported by written documentation detailing the diagnosis and pre-operative phase, the peri- and post-operative phase, and pre-operative chemotherapy, radiotherapy and surgical reconstruction, with additional guidance under development.
  • Clinical information systems include the establishment of a database and biobank. Providers receive feedback on delays (for example between diagnosis and treatment) and the number of new cases of breast cancer per year (a target is set at 150 new cases of breast cancer included in the clinical pathway per annum). Surgeons also receive specific information relating, for example, to the number of reoperations needed because safe histological margins were not reached, or the number of times that a surgeon was the main operator in relation to the total number of breast cancer operations.

All health professionals involved in the programme are employed by Lausanne University Hospital. Specialist physicians include oncologists, surgeons, plastic surgeons, fertility specialists and geneticists, radiologists and pathologists. Nurses are represented by breast cancer nurse specialists, oncology nurse specialists and generalist nurses. Allied health professionals such as physiotherapists, psychologists and social workers are also part of the team; however, social workers are not employed by the hospital but are associated with the ligue vaudoise contre le cancer.

Currently, Lausanne University Hospital takes care of approximately 200 new breast cancer patients per year. The main objective of the programme is to reach at least 150 patients included each year, which corresponds to the minimum requested for the Swiss Cancer League label. The programme is also aimed at increasing the recruitment of patients by working in a network with regional hospitals, in order to reach 40% of new breast cancer patients in the canton of Vaud. The programme is financed by the hospital itself with the Medical Director Board and chief executive actively encouraging the continuing implementation and development of the programme as well as reaching targets.

Evaluation

The programme has been evaluated, both in terms of implementation and outcomes within the accreditation process of the Swiss Cancer League Label. Based on results achieved by the clinical team, long-lasting resources were secured by Lausanne University Hospital to sustain this pathway. Internal and external systematic monitoring of process and outcome indicators will continue to be undertaken every year. The external monitoring is undertaken by the Swiss Cancer League; data will be collected in the Swiss Breast Center DataBase

The programme forms part of the strategic plan of Lausanne University Hospital, which targets the launching of a comprehensive cancer centre; it does not involve specific incentives for the development of or participation in the pathway. Incentives are indirect, for example, the need to attract patients by means of a Swiss quality label.

Programme cantonal diabète, canton of Vaud

In 2008, the Ministry of Health of the canton of Vaud (Département de la santé et de l’action sociale) initiated the development of a cantonal diabetes programme within the framework of the canton’s 20082010 health policy strategy (Rapport du Conseil d’État sur la politique sanitaire 2008–2012) (Canton de Vaud, 2008). It involved representatives from the range of providers involved in the delivery of diabetes care and other stakeholders in the health care system, including public hospitals and health insurance funds. The cantonal programme aims to sustainably reduce the impact of diabetes on the population of Vaud by reducing its incidence through appropriate preventive measures and improving the management of those with established disease (Canton de Vaud, 2014).

The programme is principally based on the Chronic Care Model developed by Wagner (1998). It plans to emphasize quality and access to self-management education, multi/interdisciplinarity, coordination and the integration of evidence-based care, health professionals’ training and health promotion and disease prevention at the general population level. This is expected to be accompanied by some form of information system.

The programme is still under development, involving a stepwise, bottom-up and top-down approach. By the end of 2013, around 40 projects had been launched (Canton de Vaud, 2013). After a first concept and campaign for early diagnosis and targeted screening for diabetes and associated risk factors, further achievements were, among others: (i) the establishment of a cohort of patients with diabetes to monitor the quality of their care, patient needs, the knowledge and exposure to the programme and its effect on the population of patients with diabetes; (ii) the adaptation of diabetes guidelines to the Swiss context; (iii) the development of a diabetes risk assessment website; and (iv) the implementation of programmes targeting physical activity of type 2 diabetic patients, of programmes promoting self-management and of patient education programmes awareness for health care professionals. The programme cantonal is also participating in partnerships to promote healthier lifestyles and considers an implementation as well as effectiveness evaluation.

Réseau de santé Delta, canton of Geneva

The Réseau de santé Delta was developed in 1992 as a health maintenance organization (HMO), on the initiative of two physicians at the University of Geneva. Initially restricted to university staff and students, the HMO was subsequently (1994) opened to other members and transformed into a network of physicians (‘Delta’) (Werblow, 2004). It is accessible to any resident of the canton of Geneva opting for the Delta network health insurance scheme. The network also operates in the canton of Vaud.

Delta’s main strategies involve elements of delivery system design and decision support.

  • Delivery system design includes the development of chronic disease management programmes for diabetes, heart failure and asthma.
  • Decision support involves the organization of regular quality circles for all physicians participating in the network.

While formal self-management support strategies are not documented, patients receive regular information (two information letters per year), detailing provisions for access to health promotion and disease prevention consultations and activities. A website is also available.

Primary care physicians (GPs, generalists, internists, family physicians) act as gatekeepers and refer patients to specialists; paediatricians, gynaecologists and ophthalmologists are directly accessible. The Delta network of physicians also includes psychologists and a network of 40 pharmacies.

The Delta network is reimbursed on a capitation basis, with re-insurance for expensive cases (Schaller & Raetzo, 2002). Participating physicians continue to be paid on a fee-for-service basis, and the capitation fee per insured person is negotiated annually between the network and the health insurance funds whose members have enrolled with the Delta network. In addition to their income, physicians receive a lump sum of CHF 200 each time they participate in a quality circle.

In January 2013, the Delta network comprised some 350 primary care physicians (70-80% generalists, internists, GPs) covering about 110 000 insurance members across the cantons of Geneva and Vaud (Delta Réseau de santé, 2014).

Evaluation

An external formal evaluation of the HMO was performed during its first three years of operation. Using a controlled before–after design based on claims data, it found a reduction in health care costs of the HMO compared with a regular insurance plan during the first year of operation, mainly through a reduction in the utilization of technical procedures such laboratory tests (Etter & Perneger, 1998). However, it also found evidence of self-selection of ‘better’ risks into the plan. Overall utilization of services did not change and there was no evidence of changes in the health status among those enrolled with the HMO.

There is no documented evidence of further evaluations being carried out following Delta’s transformation into a network and the introduction of capitation payment in 2000. However, according to evaluations performed by the involved health insurance companies, economies within the network range between 15–18% when considering age, gender and co-morbidities (Schaller, personal communication, 2014).

13.3. A patient journey

In Switzerland, there are only few opportunities to participate in structured chronic disease management programmes for diabetes or other chronic conditions. Therefore, the quality, coordination and integration of care will mainly depend on primary care physicians, and specialist physicians, and occasionally, on nurses as well as other health care professionals.

This section describes the journey of two hypothetical typical patients with co-morbid chronic disease in the Swiss health care system.

(A) A 54-year-old woman with type 2 diabetes and COPD who has a leg ulcer and moderate retinopathy. The patient is also slightly overweight (BMI of 27). She has been unemployed for three years and receives social assistance benefits; she lives on her own.

Her diabetes would typically be diagnosed by a primary care physician (GP or general-internal physician), who checks glucose levels because of the presence of overweight or other risk factors for diabetes or metabolic syndrome. Following confirmation of the diagnosis, the physician would then look for evidence of complications (heart, kidney, eye) and for other cardiovascular risk factors (dyslipidemia, physical inactivity, alcohol or tobacco use). The initial management by the primary care physician will include counselling on cardiovascular risk factors with particular attention to addressing overweight in this patient.

If disease progression is at an early stage, the primary care physician would only occasionally refer her on to an endocrinologist or diabetologist except in cases of switch to insulin, uncontrolled glycaemic levels, difficult treatment adaptations or adjustments, complexity of the case, or on specific request by the patient (second opinion or specialist visit desired). She would however be referred to an ophthalmologist for the first and subsequent eye checks. She would also be referred on to the appropriate specialist (angiologist, dermatologist or orthopaedist) for her leg ulcer, as well as to a nephrologist, if judged necessary.

Appropriate self-management education is not routinely available and access varies according to the region of residence of the patient (rural versus urban residence, for example) or the type of practice the patient is attending (hospital outpatient clinic, community-based solo or group private practice). Some primary care physicians may refer patients to a specialist nurse or a dietician for self-management education.

The diagnosis of COPD may be suspected on the basis of the patient’s history (respiratory symptoms, history of smoking), and she will either undergo basic lung function tests directly at the practice, or be referred on to a pulmonologist for full lung function tests. In the latter case, the specialist issues the diagnosis and also provides treatment recommendations following which the patient would usually return to her primary care physician to commence treatment of her condition. Her primary care physician might also refer her to obtain a second opinion or when the recommended treatment is not effective. Whether or not she will also be referred to pulmonary rehabilitation, self-management education or smoking cessation will depend on her primary care physician, but this does not occur frequently. There may also be additional barriers to participate in such programmes such as location of the patient (remote area).

In some cases, diagnoses of a given chronic diseases and initiation of treatment takes place during an incidental hospitalization for some other reason. In such case, the patients would return to her primary care physician for further management of the chronic condition.

As the patient receives social assistance, she will be in contact with social workers located in her community residence. However, the primary care physician would pay particular attention to her psychosocial situation, and organize home health care if necessary. Since basic comprehensive insurance coverage is compulsory in Switzerland, she should not encounter problems in accessing medication. If financial problems arise, she may qualify for financial assistance to help her pay health insurance premiums. Self-management education sessions provided by nurses or a dietician are generally reimbursed within the basis basket of service. However, feet control or treatment are only reimbursed if they are provided by a specialist nurse for established foot or leg ulcers or lesions; visits are not reimbursable when scheduled for preventive purposes or when provided by podologists.

(B) A 76-year-old retired engineer with chronic heart failure, severe asthma and high blood pressure. He lives with his 73-year-old wife who cares for him, while herself suffering from arthritis. They live on the third floor in a housing block and are increasingly housebound due to their illness. They are determined to remain independent; their grandson, who lives nearby, does the daily shopping for them.

The diagnosis of heart failure will likely have been made by the primary care physician, on the basis of symptoms, examination or basic investigation such as chest X-ray. His physician will then initiate treatment and follow-up of the patient as needed. Referral to a cardiologist is not systematic, especially for very old patients, even if only for a diagnostic echocardiography.

Most often, the diagnosis of asthma is suspected on the basis of the patient’s history. He will then either undergo basic lung function tests directly at the practice, or be referred to a pulmonologist for full lung function tests. In the latter case, the specialist issues the diagnosis and also gives treatment recommendations following which the patient would usually go back to his primary care physician to commence treatment of his condition. His primary care physician might also refer him on to obtain a second opinion or the recommended treatment is not effective. Blood pressure will be routinely checked and hypertension diagnosed by the primary care physician. The physician will also initiate treatment and provide counselling on cardiovascular risk factors such as diet, physical activity and smoking cessation where relevant and appropriate.

Access to self-management education for heart failure or asthma may be organized, but as with the case of the diabetes patient described earlier, this will depend on the treating physician or regional access to such programmes. Nevertheless, this occurs less frequently than in the case of diabetes.

Home health care organizations will be contacted swiftly for a comprehensive psychosocial assessment that takes account of the patient’s wishes. Home health care may include basic care (medication, personal hygiene) by health auxiliaries as well as medical care such as blood pressure and weight checks, delivered by a nurse. As long as it is prescribed by a physician, such care is reimbursed by the health insurance. Additionally, this patient could attend a day-care centre or benefit from short stays (maximum three weeks) in nursing homes (long-term care facilities).

13.4. Summary and conclusion

One of the main challenges facing the Swiss health care system remains continued fragmentation as a consequence of the federal structure and the division of responsibilities. This constitutes a major barrier for the implementation of a nationwide public health strategy and a more rational organization of health care. Much of the health reform agenda during the past decade was driven by cost-containment efforts. Despite the absence of a national regulatory framework targeting prevention and care of chronic diseases, national strategies and programmes have been developed within a growing recognition of the need to address chronic disease in the health care system. In addition, several small-scale pilot and preliminary structured care programmes have been implemented in selected localities. The latter are however still too few and limited in scope to cover the needs of the majority of patients with chronic diseases residing in Switzerland. Given the continued high satisfaction with the system among health care users, of around 80%, pressure to actually initiate larger scale changes might not yet be sufficiently strong.

Footnotes

3

Care networks as defined by the 2007 Vaud cantonal legislation include regional health care providers and other interested parties representing the entire range of services, including preventive, curative, palliative medical and social rehabilitation. Their main purpose is to strengthen the coordination across the continuum of care.

© World Health Organization 2015 (acting as the host organization for, and secretariat of, the European Observatory on Health Systems and Policies)
Bookshelf ID: NBK458747

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.7M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...